Johnson & Johnson tops 1Q expectations on broad sales bump
Updated : April 17, 2018 05:28 PM IST
The New Brunswick, New Jersey, company reported net income of $4.37 billion, or $1.60 per share, down from $4.42 billion, or $1.81 per share, in 2017's first quarter.
Marketing and production costs were higher partly because of the launch of its new severe psoriasis drug, Tremfya, approved last summer.
The world's biggest maker of health care products reported that overseas sales jumped 20%, buoyed by favorable currency exchange rates.
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morning
YOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more